Division of Molecular Medicine and Gene Therapy
111 – 120 of 619
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Reprogramming Stars #7 : Dynamic Pluripotent Stem Cell States and Their Applications-An Interview with Dr. Jun Wu
- Contribution to journal › Debate/Note/Editorial
-
Mark
BMPR1a Is Required for the Optimal TGFβ1-Dependent CD207+ Langerhans Cell Differentiation and Limits Skin Inflammation through CD11c+ Cells
- Contribution to journal › Article
-
Mark
Eliciting Anti-Tumor Immunity by Reprogramming Cancer Cells to Type 1 Conventional Dendritic Cells
(2022) European Association for Cancer Research 2022 - Congress
- Contribution to conference › Poster
-
Mark
Harnessing Dendritic Cell Reprogramming to Elucidate Mechanisms of Tumor Immunity
(2022) Lund Stem Cell Center Retreat
- Contribution to conference › Poster
-
Mark
Cell-type profiling in salamanders identifies innovations in vertebrate forebrain evolution
- Contribution to journal › Article
-
Mark
Regulome analysis in B-acute lymphoblastic leukemia exposes Core Binding Factor addiction as a therapeutic vulnerability
- Contribution to journal › Article
-
Mark
Modeling normal and malignant hematopoiesis in vitro. To screen for extrinsic regulators and differentiation therapy.
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Epicardium-derived cells organize through tight junctions to replenish cardiac muscle in salamanders
- Contribution to journal › Article
-
Mark
Human CIDEC transgene improves lipid metabolism and protects against high-fat diet–induced glucose intolerance in mice
- Contribution to journal › Article
-
Mark
Schlafen2 is a regulator of quiescence in adult murine hematopoietic stem cells
- Contribution to journal › Article
